Ovidio de Filippo, Francesco Bruno, Tineke H Pinxterhuis, Mariusz Gąsior, Leor Perl, Luca Gaido, Domenico Tuttolomondo, Antonio Greco, Roberto Verardi, Gianluca Lo Martire, Mario Iannaccone, Attilio Leone, Gaetano Liccardo, Serena Caglioni, Rocio González Ferreiro, Giulio Rodinò, Giuseppe Musumeci, Giuseppe Patti, Irene Borzillo, Giuseppe Tarantini, Wojciech Wańha, Bruno Casella, Eline H Ploumen, Łukasz Pyka, Ran Kornowski, Andrea Gagnor, Raffaele Piccolo, Sergio Raposeiras Roubin, Davide Capodanno, Paolo Zocca, Federico Conrotto, Gaetano M De Ferrari, Clemens von Birgelen, Fabrizio D'Ascenzo
BACKGROUND: Data about the long-term performance of new-generation ultrathin-strut drug-eluting stents (DES) in challenging coronary lesions, such as left main (LM), bifurcation, and chronic total occlusion (CTO) lesions are scant. METHODS: The international multicenter retrospective observational ULTRA study included consecutive patients treated from September 2016 to August 2021 with ultrathin-strut (<70 µm) DES in challenging de novo lesions. Primary endpoint was target lesion failure (TLF): composite of cardiac death, target-lesion revascularization (TLR), target-vessel myocardial infarction (TVMI), or definite stent thrombosis (ST)...
May 26, 2023: Catheterization and Cardiovascular Interventions